Filtered By:
Therapy: Antiviral Therapy
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 305 results found since Jan 2013.
The American College of Nuclear Medicine Guidance on Operating Procedures for a Nuclear Medicine Facility During COVID-19 Pandemic
The novel coronavirus 2 pandemic is causing widespread disruption in everyday life necessitating urgent and radical adaptations in operating procedures at nuclear medicine facilities. The potential for causing severe illness, COVID-19, calls for strict observance of preventive measures aimed to mitigate the spread of the virus. The threat of COVID-19 is particularly serious as there is no vaccine and no specific antiviral therapy. Further complications are introduced by shortages of personal protective equipment for healthcare workers who have direct contact with patients and effective testing to identify infected patients...
Source: Clinical Nuclear Medicine - June 11, 2021 Category: Nuclear Medicine Tags: From the American College of Nuclear Medicine Source Type: research
The Future of COVID-19 Therapies and Vaccines
Against all odds and breaking development records, we now have several approved COVID-19 vaccines rolling out worldwide. No need for DIY vaccines; these research-backed shots have repeatedly been shown to prevent SARS-CoV-2 infections and its spread. In May, following new evidence of efficacy in children, the FDA further approved administering the Pfizer / BioNTech COVID-19 vaccine to children aged between 12 and 15 years. Before, only those aged 16 and up could get the vaccine but vaccinating more children will be key to achieving herd immunity and ending the pandemic.
With such a promising outlook of available vaccine...
Source: The Medical Futurist - June 1, 2021 Category: Information Technology Authors: Pranavsingh Dhunnoo Tags: Covid-19 Digital Health Research therapy Fauci cdc vaccine pfizer Moderna SARS SARS-CoV-2 trials Duke Human Vaccine Institute Altimmune Nigel McMillan Source Type: blogs
Efficacy and safety of sofosbuvir/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial
ConclusionsAlthough treatment with SOF/VEL was safe, adding SOF/VEL to the standard of care did not improve the clinical status or reduce mortality in patients with moderate to severe COVID-19. However, larger randomized clinical trials including more parameters are needed for accurate estimation of the efficacy of SOF/VEL.
Source: Journal of Antimicrobial Chemotherapy - May 25, 2021 Category: Microbiology Source Type: research
Efficiency of antiviral treatment in COVID-19
Exp Ther Med. 2021 Jun;21(6):648. doi: 10.3892/etm.2021.10080. Epub 2021 Apr 19.ABSTRACTThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is responsible for generating a global effort to discover urgent therapeutic solutions to limit the human damage caused by COVID-19. In the period of April to June 2020, 105 patients diagnosed with COVID-19 met the conditions for inclusion in the present study. They were treated with antiviral therapy according to local guidelines: D group (53 cases), treated with darunavir/ritonavir (DRV/r); and K group (52 cases), treated with lopinavir/ritonavir (LPV/r). Patien...
Source: Experimental and Therapeutic Medicine - May 10, 2021 Category: General Medicine Authors: Nicoleta Negrut Adriana Codrean Ioana Hodisan Simona Bungau Delia Mirela Tit Ruxandra Marin Tapan Behl Florin Banica Camelia C Diaconu Delia Carmen Nistor-Cseppento Source Type: research
CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
This article summarizes the existing applications of CRISPR/Cas technology in infectious diseases with the aim of providing effective strategies for the prevention and control of COVID-19 and other emerging infectious diseases in the future.
Source: Frontiers in cellular and infection microbiology - April 23, 2021 Category: Microbiology Source Type: research
A Review of the Current Status of Clinical Management of COVID-19 in the Elderly
This article reviews the effects of COVID-19 and makes management suggestions for elderly patients during this epidemic period. In addition to the elderly, critically ill people are also highly susceptible to this novel coronavirus. For elderly COVID-19 patients, antiviral therapy, immune regulation, and even auxiliary respiratory therapy can be given after a comprehensive evaluation of the disease. With the approval and use of COVID-19 vaccines, it is reasonable to expect that we can conquer SARS-CoV-2.PMID:33833211 | DOI:10.12659/MSM.930278
Source: Medical Science Monitor - April 9, 2021 Category: Research Authors: Qiaoyun Li Chengyu Zhao Source Type: research
Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
Biomed Pharmacother. 2021 Mar 16;138:111518. doi: 10.1016/j.biopha.2021.111518. Online ahead of print.ABSTRACTSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2020 and coronavirus disease 19 (COVID-19) was later announced as pandemic by the World Health Organization (WHO). Since then, several studies have been conducted on the prevention and treatment of COVID-19 by potential vaccines and drugs. Although, the governments and global population have been attracted by some vaccine production projects, the presence of SARS-CoV-2-specific antiviral drugs would be an urge necessit...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - March 28, 2021 Category: Drugs & Pharmacology Authors: Mona Sadat Mirtaleb Amir Hossein Mirtaleb Hassan Nosrati Jalal Heshmatnia Reza Falak Reza Zolfaghari Emameh Source Type: research
